PF-AtlasClinical Trials › NCT02433132

Cystic Fibrosis Diagnosis by Analyzing Nasal Brushing

Nasal brushing · Not specified

Registry ID
NCT02433132
Phase
Not specified
Status
Unknown
Drug / intervention
Nasal brushing
Sponsor
Assistance Publique - Hôpitaux de Paris
Start
2015-03
Enrollment
128
Locations
1

About this trial

The diagnosis of CF is currently based on the discovery of two CFTR gene mutations and / or a positive sweat test (\> 60mmol / l). A significant number of patients with atypical cystic fibrosis (chronic sino-pulmonary disease with a single mutation in the CFTR gene and / or a test of the intermediate sweat between 30 and 60 mmol / l) undetected by these techniques are behind specialized care while irreversible lung damage is already existed. Currently, the measurement of nasal potential difference in vivo (DPN), which evaluates the transportation of chlorine in the nasal epithelium with an electrode, is proposed for the diagnosis of atypical forms. However DPN dependent nasal local conditions when analysing do not always offer the possibility of concluding the diagnosis of cystic fibrosis. It is necessary to develop new and more reliable diagnostic tests for the detection of cases of atypical cystic fibrosis. The authors propose to develop a new diagnostic technique based on the study of bioelectric properties of a preparation of nasal cells of the subject obtained by brushing and placed in primary culture (CCBN).

View NCT02433132 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT02433132 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.